AIM ImmunoTech Inc.
AIM
$9.21
$0.9110.96%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.71M | -5.97M | -3.70M | -1.84M | -5.82M |
| Total Depreciation and Amortization | 58.00K | 64.00K | 63.00K | 61.00K | 58.00K |
| Total Amortization of Deferred Charges | 64.00K | 69.00K | -38.00K | 197.00K | 73.00K |
| Total Other Non-Cash Items | 432.00K | 464.00K | 180.00K | 840.00K | 105.00K |
| Change in Net Operating Assets | 790.00K | 1.42M | 385.00K | -2.27M | 766.00K |
| Cash from Operations | -2.36M | -3.96M | -3.11M | -3.01M | -4.82M |
| Capital Expenditure | -- | 0.00 | -18.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 898.00K | 3.70M | 352.00K | 826.00K | -158.00K |
| Cash from Investing | 898.00K | 3.70M | 334.00K | 826.00K | -158.00K |
| Total Debt Issued | -- | 0.00 | 133.00K | -133.00K | 2.50M |
| Total Debt Repaid | -- | -251.00K | -- | -- | -- |
| Issuance of Common Stock | 660.00K | 32.00K | 4.00K | 527.00K | 329.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 1.26M | 0.00 | 2.05M | -- |
| Cash from Financing | 660.00K | 1.04M | 137.00K | 2.44M | 2.83M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -803.00K | 786.00K | -2.64M | 259.00K | -2.14M |